TREASURE TAKANG-ENOW: Open Payments
NPI 1336544022 · MAPLE GROVE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $42 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Qelbree, FANAPT, ARISTADA, TRINTELLIX, COBENFY, Auvelity.
Industry payments across MN — which companies pay providers there.
